CD8A and myeloid sarcoma: As the most well-recognized assessment in evaluating MS patients, EDSS scores were employed to explore the association between disabilities and peripheral GzmB + CD8 + T cells, GzmB + CD8 + TEM cells, or GzmB + CD8 + TEMRA cells, respectively.